1-氨基甲酰-1-环丙烷羧酸 | 6914-74-5

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪酸
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 1-氨基甲酰-1-环丙烷羧酸
• 中文别名: 1-甲酰胺基-1-环丙烷羧酸；1-羧基环戊烷甲酰胺；1-氨基羰酰-1-环丙烷羧酸
• 英文名称: 1-carbamoylcyclopropanecarboxylic acid
• 英文别名: 1-carbamoylcyclopropane-1-carboxylic acid；1-aminocarbonylcyclopropanecarboxylic acid；1-Carboxycyclopropanecarboxamide
• CAS: 6914-74-5
• 化学式: C₅H₇NO₃
• mdl: MFCD00190650
• 分子量: 129.115
• InChiKey: SDHXFKBMHSJXHA-UHFFFAOYSA-N

物化性质

• 熔点：
  185 °C (dec.)(lit.)
• 沸点：
  239.15°C (rough estimate)
• 密度：
  1.3816 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  80.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  存储条件：室温、密闭且干燥环境中

SDS

Name:	1-(Aminocarbonyl)-1-cyclopropanecarboxylic acid, 97% Material Safety Data Sheet
Synonym:	None.
CAS:	6914-74-5

Section 1 - Chemical Product MSDS Name: 1-(Aminocarbonyl)-1-cyclopropanecarboxylic acid, 97% Material Safety Data Sheet
Synonym: None.

---

SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
6914-74-5	1-(Aminocarbonyl)-1-cyclopropanecarbox	97	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

SECTION 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated. Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

SECTION 4 - FIRST AID MEASURES
Eyes:
Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

SECTION 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

SECTION 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation.

---

SECTION 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 6914-74-5: Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Decomposes
Freezing/Melting Point: 185 deg C (dec)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: > 185 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H7NO3
Molecular Weight: 129.12

---

SECTION 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

SECTION 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 6914-74-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(Aminocarbonyl)-1-cyclopropanecarboxylic acid - Not listed by ACGIH, IARC, or NTP.

---

SECTION 12 - ECOLOGICAL INFORMATION

---

SECTION 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations.

---

SECTION 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material.

---

SECTION 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 28A After contact with skin, wash immediately with plenty of water. S 37 Wear suitable gloves. S 37/39 Wear suitable gloves and eye/face protection. S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). WGK (Water Danger/Protection) CAS# 6914-74-5: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 6914-74-5 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 6914-74-5 is not listed on the TSCA inventory. It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
MSDS Creation Date: 3/08/1999 Revision #2 Date: 3/18/2003 The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-氨基甲酰-1-环丙烷羧酸 在 sodium hydroxide 、 水 、 溴 、 盐酸 作用下， 以 水 为溶剂， 反应 21.5h， 生成 1-氨基环丙烷羧酸
  参考文献：
  名称：

  Purification and production methods of 1-aminocyclopropanecarboxylic acid

  摘要：

  一种方法通过将粗1-氨基环丙烷羧酸与含有一个至五个碳原子的有机酸和一种对1-氨基环丙烷羧酸为劣溶剂的溶剂混合物结晶来纯化1-氨基环丙烷羧酸。在该方法中，溶剂混合物还可以含有水。可以通过将粗1-氨基环丙烷羧酸与含有一个至五个碳原子的有机酸混合，通过过滤去除不溶物，并向滤液中加入带或不带水的劣溶剂来结晶1-氨基环丙烷羧酸来进行纯化。

  公开号：

  US20060030730A1
• 作为产物：
  描述：

  1-氰基环丙基甲酸乙酯 在 sodium hydroxide 、 双氧水 作用下， 生成 1-氨基甲酰-1-环丙烷羧酸
  参考文献：
  名称：

  Stereochemical studies on the reactions catalyzed by the PLP-dependent enzyme 1-aminocyclopropane-1-carboxylate deaminase

  摘要：

  DOI：

  10.1021/ja00330a050

文献信息

• [EN] INHIBITORS OF APOL1 AND USE OF THE SAME<br/>[FR] INHIBITEURS D'APOL1 ET LEUR UTILISATION
  申请人：VERTEX PHARMA

  公开号：WO2021252859A1

  公开（公告）日：2021-12-16

  The disclosure provides at least one compound, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of formula (I), deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of making and using the same, including use in treating APOL1 mediated kidney disease.

  本公开提供了至少一种化合物、重氢化衍生物或药用可接受的盐，选自公式(I)化合物、其重氢化衍生物以及任何前述物质的药用可接受的盐，包含同一的组成物，以及制造和使用同一的方法，包括用于治疗APOL1介导的肾脏疾病。
• A solvent-reagent selection guide for Steglich-type esterification of carboxylic acids
  作者：Andrew Jordan、Kyran D. Whymark、Jack Sydenham、Helen F. Sneddon

  DOI：10.1039/d1gc02251b

  日期：——

  The Steglich esterification is a widely employed method for the formation of esters under mild conditions. A number of issues regarding the sustainability of this transformation have been identified, chiefly the use of hazardous carbodiimide coupling reagents in conjunction with solvents with considerable issues such as dichloromethane (DCM) and N,N-dimethylformamide (DMF). To overcome these issues

  Steglich 酯化是一种广泛采用的在温和条件下形成酯的方法。已经确定了许多与这种转变的可持续性有关的问题，主要是使用危险的碳二亚胺偶联试剂与溶剂结合使用，这些溶剂具有相当大的问题，例如二氯甲烷 (DCM) 和N , N-二甲基甲酰胺 (DMF)。为了克服这些问题，我们已经开发了用于形成酯的溶剂的试剂选择导引装置经由Steglich 型反应，旨在提供更安全、更可持续的条件。在对溶剂-试剂组合进行高通量筛选后，确定了最佳反应条件，即使用 Mukaiyama 试剂 (Muk) 和溶剂碳酸二甲酯 (DMC)。新的反应条件也通过合成少量的结构单元类分子来举例说明，包括叔丁酯的形成。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2010019637A1

  公开（公告）日：2010-02-18

  The invention is directed to pyrido[4,3-d]pyrimidin-5(6H)-one derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R1, R2, R3, and R4 are defined below. The compounds of the invention are inhibitors of PDK1 and can be useful in the treatment of disorders characterized by constitutively activated ACG kinases such as cancer and more specifically cancers of the breast, colon, and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting PDK1 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention

  这项发明涉及吡啶并[4,3-d]嘧啶-5(6H)-酮衍生物。具体而言，该发明涉及符合以下式(I)的化合物，其中R1、R2、R3和R4如下所定义。该发明的化合物是PDK1的抑制剂，可用于治疗由于ACG激酶持续活化而表现出的疾病，如癌症，尤其是乳腺癌、结肠癌和肺癌。因此，该发明进一步涉及包含该发明化合物的药物组合物。该发明还进一步涉及使用该发明化合物或包含该发明化合物的药物组合物来抑制PDK1活性和治疗相关疾病的方法。
• A COMPOUND FOR INHIBITING 11B-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  申请人：Lee Inhee

  公开号：US20140206875A1

  公开（公告）日：2014-07-24

  Disclosed are a novel compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition including the same for inhibiting human 11-β-hydroxy steroid dehydrogenase type 1 (11β-HSD1). The disclosed compound and the pharmaceutical composition including the same for inhibiting human 11-β-hydroxy steroid dehydrogenase type 1 (11β-HSD1) are excellent in activity and solubility, and is more efficient in formulation and transfer.

  本文披露了一种新型化合物或其药用可接受的盐，以及包括该化合物的药物组合物，用于抑制人类11-β-羟基类固醇脱氢酶1型（11β-HSD1）。所披露的化合物和包括该化合物的药物组合物用于抑制人类11-β-羟基类固醇脱氢酶1型（11β-HSD1）在活性和溶解性方面表现出色，并且在配方和转移方面更为高效。
• B(OCH₂CF₃)₃-mediated direct amidation of pharmaceutically relevant building blocks in cyclopentyl methyl ether
  作者：Valerija Karaluka、Rachel M. Lanigan、Paul M. Murray、Matthew Badland、Tom D. Sheppard

  DOI：10.1039/c5ob01801c

  日期：——

  The direct amidation of pharmaceutically relevant carboxylic acids and amines with B(OCH₂CF₃)₃ in cyclopentyl methyl ether (CPME) is described.

  在环戊基甲醚（CPME）中，使用B(OCH2CF3)3直接对具有药用相关性的羧酸和胺进行酰胺化反应。